Profil
Abraham Heifets is the founder of Atomwise, Inc. He currently holds a position as Director at X-37 Service Co., Inc.
Aktive Positionen von Abraham Heifets
Unternehmen | Position | Beginn |
---|---|---|
Atomwise, Inc.
Atomwise, Inc. Medical DistributorsDistribution Services Atomwise, Inc. develops artificial intelligence systems. It specializes in drug discovery and machine learning. The company was founded by Abraham Heifets, Izhar Wallach and Alexander Levy and is headquartered in Wilmington, DE. | Gründer | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Atomwise, Inc.
Atomwise, Inc. Medical DistributorsDistribution Services Atomwise, Inc. develops artificial intelligence systems. It specializes in drug discovery and machine learning. The company was founded by Abraham Heifets, Izhar Wallach and Alexander Levy and is headquartered in Wilmington, DE. | Distribution Services |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | Commercial Services |